T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
American Vanguard Corp
AVD
$65.2M
| $29.9M | ﹤0.01% |
1,941,870
-13,089
| -0.7% | -$200K |
|
1052
Lennar Class A
LEN
$21B
| $29.9M | ﹤0.01% |
636,518
-5,019
| -0.8% | -$250K |
|
|
PDCE
1053
DELISTED
PDC Energy, Inc.
PDCE
| $29.8M | ﹤0.01% |
826,052
-3,001
| -0.4% | -$113K |
|
|
FRGI
1054
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $29.8M | ﹤0.01% |
2,264,539
-1,812,000
| -44% | -$24.2M |
|
1055
Best Buy
BBY
$18B
| $29.8M | ﹤0.01% |
426,709
+2,396
| +0.6% | +$167K |
|
1056
Clarivate
CLVT
$1.19B
| $29.7M | ﹤0.01% |
+1,931,190
| New | +$26.9M |
|
1057
Prestige Consumer Healthcare
PBH
$2.41B
| $29.6M | ﹤0.01% |
934,317
-1,222,859
| -57% | -$36.3M |
|
1058
Citizens Financial Group
CFG
$31.2B
| $29.2M | ﹤0.01% |
826,700
-7,393
| -0.9% | -$258K |
|
1059
Barclays
BCS
$94.4B
| $29.2M | ﹤0.01% |
3,922,174
-7,045
| -0.2% | -$55.6K |
|
|
RUTH
1060
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $29.1M | ﹤0.01% |
1,282,860
-5,573
| -0.4% | -$136K |
|
1061
OneSpaWorld
OSW
$2.72B
| $28.9M | ﹤0.01% |
1,866,526
+25,356
| +1% | +$350K |
|
1062
The RealReal
REAL
$1.36B
| $28.9M | ﹤0.01% |
+1,000,000
| New | +$28.9M |
|
1063
Nutanix
NTNX
$17.6B
| $28.8M | ﹤0.01% |
1,111,918
+1,074,748
| +2,891% | +$37.5M |
|
1064
Expedia Group
EXPE
$38.9B
| $28.7M | ﹤0.01% |
215,858
+4,786
| +2% | +$590K |
|
|
MSGN
1065
DELISTED
MSG Networks Inc.
MSGN
| $28.7M | ﹤0.01% |
1,382,622
-512,440
| -27% | -$11.2M |
|
1066
Wave Life Sciences
WVE
$1.07B
| $28.5M | ﹤0.01% |
1,094,013
-418,373
| -28% | -$11.7M |
|
1067
Regions Financial
RF
$27B
| $28.5M | ﹤0.01% |
1,904,984
-4,070
| -0.2% | -$60.1K |
|
1068
Cincinnati Financial
CINF
$26.5B
| $28.3M | ﹤0.01% |
273,452
-349
| -0.1% | -$33.5K |
|
1069
Douglas Dynamics
PLOW
$978M
| $28.3M | ﹤0.01% |
710,382
+1,886
| +0.3% | +$71.8K |
|
1070
NCR Voyix
VYX
$1.12B
| $28.2M | ﹤0.01% |
1,479,898
-17,166
| -1% | -$319K |
|
|
BEAT
1071
DELISTED
BioTelemetry, Inc.
BEAT
| $28.2M | ﹤0.01% |
586,023
+2,709
| +0.5% | +$142K |
|
1072
Waters Corp
WAT
$40.9B
| $28.1M | ﹤0.01% |
130,775
-7,475
| -5% | -$1.63M |
|
1073
BJs Wholesale Club
BJ
$11.9B
| $28.1M | ﹤0.01% |
1,065,258
+29,379
| +3% | +$781K |
|
1074
A.O. Smith
AOS
$8.44B
| $28.1M | ﹤0.01% |
594,833
-19,188
| -3% | -$941K |
|
|
MTOR
1075
DELISTED
MERITOR, Inc.
MTOR
| $28M | ﹤0.01% |
1,154,290
+1,101,070
| +2,069% | +$24.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.